| Bioactivity | KHK-IN-5 (Compound 18) is a KHK inhibitor. KHK-IN-5 can be used for the research of nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), and type 2 diabetes (T2DM)[1]. |
| CAS | 3043939-40-5 |
| Formula | C20H21F2N5S |
| Molar Mass | 401.48 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Sabnis RW. Novel Cyanopyridine Compounds as KHK Inhibitors for Treating NAFLD, NASH, and Type II Diabetes. ACS Med Chem Lett. 2024 Jul 23;15(8):1191-1192. |
KHK-IN-5
CAS: 3043939-40-5 F: C20H21F2N5S W: 401.48
KHK-IN-5 (Compound 18) is a KHK inhibitor. KHK-IN-5 can be used for the research of nonalcoholic fatty liver disease (NA
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.